NIHON CHOUZAI Co.,Ltd. (TYO:3341)
Japan
· Delayed Price · Currency is JPY 3,025.00
+45.00 (1.51%)
May 22, 2025, 9:35 AM JST
NIHON CHOUZAI Revenue
In the fiscal year ending March 31, 2025, NIHON CHOUZAI had annual revenue of 360.51B JPY with 5.94% growth. NIHON CHOUZAI had revenue of 90.71B in the quarter ending March 31, 2025, with 5.26% growth.
Revenue
360.51B
Revenue Growth
+5.94%
P/S Ratio
0.25
Revenue / Employee
61.48M
Employees
5,864
Market Cap
90.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 360.51B | 20.20B | 5.94% |
| Mar 31, 2024 | 340.31B | 26.99B | 8.61% |
| Mar 31, 2023 | 313.32B | 13.93B | 4.65% |
| Mar 31, 2022 | 299.39B | 20.44B | 7.33% |
| Mar 31, 2021 | 278.95B | 10.43B | 3.88% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |